SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : HuMAB companies
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Icebrg who wrote (649)6/22/2004 11:30:06 AM
From: Icebrg  Read Replies (1) of 1022
 
Curagen and Seattle Genetics.

Interesting to note from today's PR that the cooperation between CRGN and ABGX seems to have resulted in something workable.

I guess IMGN feels a little bit pi**sed off today as they are supposed to be ABGX's partner for this type of mAb-enhancement. Although we have not yet seen any results yet despite Abgenix having a head-start of abt. three years. As a matter of fact Withy recently said, that they were not going to pursue any development of mAb-conjugates unless they are able to partner the program.

Erik
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News